4//SEC Filing
Kurtz Ronald M MD 4
Accession 0000950170-24-003332
CIK 0001111485other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:08 PM ET
Size
7.7 KB
Accession
0000950170-24-003332
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Kurtz Ronald M MD
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-01-08$43.50/sh−31,250$1,359,375→ 835,860 total(indirect: See footnote) - Sale
Common Stock
2024-01-08$45.00/sh−31,250$1,406,256→ 804,610 total(indirect: See footnote)
Holdings
- 40,000
Common Stock
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
- [F2]Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
- [F3]Represents the weighted average share price of an aggregate total of 31,250 shares sold in the price range of $45.00 to $45.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
RxSight, Inc.
CIK 0001111485
Entity typeother
Related Parties
1- filerCIK 0001295469
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:08 PM ET
- Size
- 7.7 KB